Literature DB >> 12617385

Whiplash-associated disorders--predicting disability from a process-oriented perspective of coping.

Anne Söderlund1, Per Lindberg.   

Abstract

OBJECTIVE: To describe the coping process over time for patients with whiplash-associated disorders (WAD).
DESIGN: The study was conducted by following patients prospectively for 12 months. SETTINGS: The orthopaedic clinic at a university hospital.
SUBJECTS: Fifty-three patients out of 59 had complete data-sets. MAIN OUTCOME MEASURES: Two measures were used: the Pain Disability Index (PDI) and the Coping Strategies Questionnaire (CSQ).
RESULTS: The results showed that the proportion of variance in disability shared with coping increased over time.
CONCLUSION: The importance of coping as an explanatory factor for disability increased during the one year follow-up. Thus, coping has a crucial role for disability. The possibility of a positive long-term outcome could therefore be improved by teaching patients to use active and adaptive coping strategies shortly after an accident.

Entities:  

Mesh:

Year:  2003        PMID: 12617385     DOI: 10.1191/0269215503cr566oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  11 in total

1.  Coping patterns and their relation to daily activity, worries, depressed mood, and pain intensity in acute whiplash-associated disorders.

Authors:  Annika Bring; Johan Bring; Anne Söderlund; Elisabet Wasteson; Pernilla Asenlöf
Journal:  Int J Behav Med       Date:  2013-06

2.  Maintaining a balance: a focus group study on living and coping with chronic whiplash-associated disorder.

Authors:  Kariann Krohne; Camilla Ihlebaek
Journal:  BMC Musculoskelet Disord       Date:  2010-07-13       Impact factor: 2.362

3.  Validation of a French-Canadian version of the Pain Disability Index.

Authors:  Nathalie Gauthier; Pascal Thibault; Heather Adams; Michael J L Sullivan
Journal:  Pain Res Manag       Date:  2008 Jul-Aug       Impact factor: 3.037

Review 4.  Rehabilitation of chronic whiplash: treatment of cervical dysfunctions or chronic pain syndrome?

Authors:  Jo Nijs; Jessica Van Oosterwijck; Willem De Hertogh
Journal:  Clin Rheumatol       Date:  2009-01-22       Impact factor: 2.980

5.  Reconstitution of lost cervical spine function: management strategies.

Authors:  Arne Ernst; Andreas Niedeggen
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

6.  Outcome of physiotherapy after surgery for cervical disc disease: a prospective randomised multi-centre trial.

Authors:  Anneli Peolsson; Birgitta Öberg; Johanna Wibault; Åsa Dedering; Peter Zsigmond; Lars Bernfort; Ann-Sofi Kammerlind; Liselott C G Persson; Håkan Löfgren
Journal:  BMC Musculoskelet Disord       Date:  2014-02-06       Impact factor: 2.362

7.  Initial healthcare and coping preferences are associated with outcome 1 year after whiplash trauma: a multicentre 1-year follow-up study.

Authors:  Solbjørg Makalani Myrtveit; Tina Carstensen; Helge Kasch; Eva Ørnbøl; Lisbeth Frostholm
Journal:  BMJ Open       Date:  2015-03-20       Impact factor: 2.692

8.  The Relation between the Fear-Avoidance Model and Constructs from the Social Cognitive Theory in Acute WAD.

Authors:  Maria Sandborgh; Ann-Christin Johansson; Anne Söderlund
Journal:  Pain Res Manag       Date:  2016-11-23       Impact factor: 3.037

9.  Interdisciplinary rehabilitation after whiplash injury: An observational prospective 5 years outcome study.

Authors:  Philipp Haiduk; Thomas Benz; Susanne Lehmann; Francoise Gysi-Klaus; André Aeschlimann; Beat A Michel; Felix Angst
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

10.  A three-group study, internet-based, face-to-face based and standard- management after acute whiplash associated disorders (WAD) - choosing the most efficient and cost-effective treatment: study protocol of a randomized controlled trial.

Authors:  Anne Söderlund; Annika Bring; Pernilla Asenlöf
Journal:  BMC Musculoskelet Disord       Date:  2009-07-22       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.